Bill Gates is funding factories for 7 potential coronavirus vaccines
Through the Bill and Melinda Gates Foundation, the billionaire Microsoft founder and philanthropist plans to help fund factories for seven promising vaccines, even before seeing conclusive data. That's despite the fact that two of the programs—at most—will make it through to final development and deployment, he said on The Daily Show with Trevor Noah.

“Our early money can accelerate things,” Gates said. The foundation is picking the seven “most promising” vaccine constructs and will help fund factories for all seven, he added, “even though we’ll end up picking at most two” to actually deploy.
“To get to the best case” of vaccine deployment in about 18 months, Gates said, “we need to do safety and efficacy and build manufacturing" simultaneously. He acknowledged the plan will result in the loss of “a few billion dollars” on projects that don’t pan out.
Still, considering the situation the world is in, “a few billion ... is worth it.” He said the effort can save critical months to making a vaccine available, and thus restart economies sooner.
Looking for chemical products? Let suppliers reach out to you!
2026-07-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
USDA Report Suggests Coronavirus May Have Spread Widely in Deer and Poses Potential Risk to Humans
-
From 'Class B A Tube' to 'Class B B tube', where is the epidemic concept stock going?
-
Pfizer to Increase Production Capacity of Coronavirus Oral Drugs, Invest 120 Million US Dollars
-
The Dangers Of Vaccines That Commenly Used
-
An Insight Into The Vaccine Causing Blood Clots
-
Overview Of The Top 5 Vaccine Companies In China
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
Analysis of the biggest producer of vaccines on coronavirus in China
-
6 Drugs Sold For Nearly $120 Billion
-
Two inactivated vaccines against COVID-19 start clinical trials